Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colorectal Neoplasms × pertuzumab × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 68 Stomach Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Inflammatory Breast Neoplasms 3 Breast Neoplasms, Male 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Carcinoma, Ductal, Breast 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Patient Preference 1 Neoplasms, Unknown Primary 1 Metastatic HER2-Positive Breast Cancer 1 Lung Neoplasms 1 Her2-Positive Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive Early Breast Cancer 1 HER2 Positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Elderly Metastatic Breast Cancer Population 1 Colorectal Neoplasms 1 Carcinoma, Neuroendocrine 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 253 Leucovorin 223 Oxaliplatin 216 Irinotecan 204 Bevacizumab 198 Capecitabine 144 Cetuximab 135 Panitumumab 67 Folfox protocol 63 regorafenib 49 Colonoscopy 44 pembrolizumab 42 IFL protocol 39 Radiotherapy 32 Nivolumab 30 Drug Therapy 27 trifluridine tipiracil drug combination 24 Gemcitabine 24 Blood Specimen Collection 23 Chemotherapy, Adjuvant 20 Surveys and Questionnaires 19 Celecoxib 17 Surgical Procedures, Operative 16 durvalumab 15 Neoadjuvant Therapy 15 Cyclophosphamide 14 Cisplatin 14 aflibercept 13 Standard of Care 13 Pemetrexed 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02291289 2024-05-06

MODUL

Hoffmann-La Roche

Phase 2 Completed

1,044 enrolled 21 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡